Unrelated stem cell transplantation (SCT) following a novel reduced intensity conditioning regimen and mycophenolate mophetil (MMF) plus cyclosporin A (CsA) as graft versus host disease (GVHD) prophylaxis.

被引：0
|
作者：
Lacerda, JF
Martins, C
Carmo, JA
Lourenco, F
Juncal, C
Ligeiro, D
Martinho, A
Lacerda, JMF
机构：
[1] Univ Lisbon, Hosp Santa Maria, Hematol & Bone Marrow Transplantat Serv, P-1699 Lisbon, Portugal
[2] Histocompatibil Ctr, Lisbon, Portugal
[3] Histocompatibil Ctr, Coimbra, Portugal
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5446
引用
收藏
页码：430B / 430B
页数：1
相关论文
共 50 条
  • [1] Clinical and laboratory features of minor ABO incompatible reduced intensity blood hematopoietic cell transplantation using cyclosporin (CsA) vs. CsA/mycophenolate mofetil (CsA/MMF) for graft-vs-host disease (GVHD) prophylaxis.
    Reese, A
    Stevens, WT
    Donohue, T
    Chakrabarti, S
    Wesley, R
    Castro, K
    Fowler, D
    Bishop, MR
    Stroncek, D
    Leitman, S
    Childs, RW
    Bolan, CD
    BLOOD, 2003, 102 (11) : 708A - 708A
  • [2] PHARMACODYNAMIC PREDICTION OF GVHD RISK IN REDUCED-INTENSITY CONDITIONING REGIMEN ALLOGENEIC STEM CELL TRANSPLANTATION (RIC ALLOSCT) USING MYCOPHENOLATE MOFETIL (MMF) PLUS CYCLOSPORINE A (CSA) AS GVHD PROPHYLAXIS
    Martinez, C.
    Millan, O.
    Rovira, M.
    Fernandez-Aviles, F.
    Suarez-Lledo, M.
    Urbano-Ispizua, A.
    Brunet, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S283 - S283
  • [3] Reduced-intensity conditioning allogeneic transplantation from unrelated donors:: Evaluation of mycophenolate mofetil plus cyclosporin a as graft-versus-host disease prophylaxis
    Perez-Simon, Jose A.
    Martino, Rodrigo
    Caballero, Dolores
    Valcarcel, David
    Rebollo, Noemi
    de la Camara, Rafael
    Perez de Oteiza, Javier
    Heras, Inmaculada
    Calvo, Maria V.
    Sierra, Jordi
    San Miguel, Jesus F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (06) : 664 - 671
  • [4] Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation
    M Mohty
    H de Lavallade
    C Faucher
    K Bilger
    N Vey
    A-M Stoppa
    G Gravis
    D Coso
    P Viens
    J-A Gastaut
    D Blaise
    Bone Marrow Transplantation, 2004, 34 : 527 - 530
  • [5] Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation
    Mohty, M
    de Lavallade, H
    Faucher, C
    Bilger, K
    Vey, N
    Stoppa, AM
    Gravis, G
    Coso, D
    Viens, P
    Gastaut, JA
    Blaise, D
    BONE MARROW TRANSPLANTATION, 2004, 34 (06) : 527 - 530
  • [6] Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic stem cell transplantation
    Kasper, C
    Mügge, L
    Schilling, K
    Scholl, S
    Wollina, K
    Höffken, K
    Sayer, H
    BONE MARROW TRANSPLANTATION, 2002, 29 : S187 - S188
  • [7] Mycophenolate mofetil in combination with cyclosporine a (CSA) ± prednisolone versus CsA, methotrexate ± prednisolone for the prophylaxis of acute GvHD after allogeneic stem cell transplantation -: MMF, a new option in GvHD prophylaxis.
    Kiehl, MG
    Linck, D
    Schaefer-Eckart, K
    Kroeger, M
    Bronhaeuser, M
    Blau, IW
    Wandt, H
    Jenke, A
    Kienast, J
    Armstrong, VW
    Basara, N
    Schroeder, H
    Kraut, L
    Fauser, AA
    BLOOD, 2003, 102 (11) : 716A - 716A
  • [8] Cyclosporin A (CSA) and Mycophenolate Mofetil (MMF) vs Cyclosporine A and Steroids for graft-versus-host disease (GVHD) prophylaxis after umbilical cord blood (CB) transplantation
    Ghemlas, Ibrahim
    Siddiqui, Khawar
    Jafri, Rafat
    Barria, Mary
    Amao, Antonette
    Alsaedi, Hawazen
    Alsweedan, Suleimman
    Alahmari, Ali
    Aljerfi, Abdullah
    Alseraihy, Amal
    Ayas, Mouhab
    BONE MARROW TRANSPLANTATION, 2018, 53 : 406 - 406
  • [9] Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors
    Kasper, C
    Sayer, HG
    Mügge, LO
    Schilling, K
    Scholl, S
    Issa, MC
    Höffken, K
    BONE MARROW TRANSPLANTATION, 2004, 33 (01) : 65 - 69
  • [10] Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors
    C Kasper
    H G Sayer
    L O Mügge
    K Schilling
    S Scholl
    M C Issa
    K Höffken
    Bone Marrow Transplantation, 2004, 33 : 65 - 69
12345